Press release
Global Pharmacogenetic Testing Market Growth Prospects, Future Industry Landscape 2033
Pharmacogenetic Testing Global Market Report 2024
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp
According to The Business Research Company's, The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $10.68 billion in 2023 to $12.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing overall drug efficacy, increasing adoption of personalized medicine, growing need for precision diagnosis, increasing focus on pharmacogenetic testing, and increasing medical expenses.
The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $22.28 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to rising research and development associated with biotechnology and healthcare, increasing healthcare expenditure, rising prevalence Of chronic diseases, increased accessibility, rise of telemedicine and digital health. Major trends in the forecast period include pharmacogenetic testing, advancements in genomic technologies, technological advancements, advances in companion diagnostics, and innovative diagnostic tests.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report
Market Drivers and Trends:
The increasing demand for personalized medicine is expected to propel the growth of the pharmacogenetic testing market going forward. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare decisions and treatments to the individual characteristics of each patient. The increasing personalized medicine is due to several factors, such as improved treatment outcomes, a focus on prevention and early detection, and cost-effectiveness. Pharmacogenetic testing is integral to personalized medicine by analyzing an individual's genetic makeup to predict how they will respond to specific medications. This enables healthcare providers to tailor treatments based on genetic factors, optimizing drug efficacy and minimizing adverse reactions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the pharmacogenetic testing market.
Major companies operating in the pharmacogenetics testing market are developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to gain a competitive edge in the market. Prescription-based pharmacogenetic testing refers to genetic tests that are specifically ordered or prescribed by healthcare providers to analyze a patient's genetic makeup before prescribing medications. For instance, in May 2023, UCSF, a US-based healthcare company, launched its pharmacogenomics testing service. It is designed to improve the precision of medical treatments. UCSF's pharmacogenomics testing service helps healthcare providers tailor drug therapies based on an individual's genetic profile, aiming to enhance drug efficacy, minimize adverse reactions, and support personalized medicine strategies.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC
Pharmacogenetic Testing Market 2024 Key Insights:
• The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $22.28 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%.
• Impact Of Personalized Medicine On The Growth Of The Pharmacogenetic Testing Market
• Advancements In Prescription-Based Pharmacogenetic Testing
• Asia-Pacific was the largest region in the pharmacogenetic testing market in 2023 and it is expected to be the fastest-growing region in the forecast period
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmacogenetic Testing Market Growth Prospects, Future Industry Landscape 2033 here
News-ID: 3722268 • Views: …
More Releases from The Business Research Company
Global Acrylic Powder Market Worth $77.43 Billion by 2029, Growing at 7.5% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Acrylic Powder Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent years, the market size of acrylic powder has experienced significant growth. It is projected to expand from $54.48 billion in 2024 to $57.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors…
Toluene Derivatives Industry to Achieve $8.45 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Toluene Derivatives Market Grow by 2025 in Terms of Size and Growth?
In recent times, the market size of toluene derivatives has considerably grown. The market is projected to rise from $5.98 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%.…
Sulfur Dioxide Market on Path to Hit $7.07 Billion by 2029 at 3.9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Sulfur Dioxide Market Outlook: What Size And CAGR Are Anticipated By 2025?
The sulfur dioxide market has seen a consistent growth in its size over the past few years. Projected to expand from $5.89 billion in 2024 to $6.08 billion in 2025, it is speculated to increase at a compound…
Release Agents Market to Surpass $1.35 Billion by 2029 | Key Trends & Insights
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Release Agents Market Grow by 2025 in Terms of Size and Growth?
The market size of release agents has seen significant growth in recent years. The market is projected to expand from a value of $1.06 billion in 2024 to $1.11 billion in 2025, with a compound annual growth…
More Releases for Pharmacogenetic
Major Growth Driver Identified in 2025 Pharmacogenetic Testing Market: Impact Of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmacogenetic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of pharmacogenetic testing has seen brisk growth in recent times and is anticipated to surge from $12.37 billion in 2024 to $14.35 billion in 2025, representing a compound annual growth rate (CAGR)…
Evolving Market Trends In The Pharmacogenetic Testing Industry: Advancements In …
The Pharmacogenetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Pharmacogenetic Testing Market Size During the Forecast Period?
The pharmacogenetic testing market size has grown from $12.37 billion in 2024 to $14.35 billion in 2025, with a CAGR of 16.1%. This…
Prominent Pharmacogenetic Testing Market Trend for 2025: Advancements In Prescri …
What Are the Projected Growth and Market Size Trends for the Pharmacogenetic Testing Market?
In recent years, the pharmacogenetic testing market scale has been expanding swiftly. The forecast predicts an increase from $12.37 billion in 2024 to $14.35 billion in 2025, manifesting a compound annual growth rate (CAGR) of 16.1%. Factors contributing to the growth during the historic period include heightened drug efficiency, the rising popularity of personalized medicine, the escalating…
Pharmacogenetic Testing Market is Expected to witness 8.70% CAGR by Forecast 202 …
The credible Pharmacogenetic Testing Market report offer actionable market insights with which businesses can make out sustainable and lucrative strategies. Not to mention, the report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. SWOT analysis has been performed while formulating this market document along with many other standard steps of researching, analyzing…
Pharmacogenetic Testing Market, Competitive Strategies, Advertising Trends, & Ma …
Pharmacogenetic Testing Market will project a CAGR of 8.70% during the forecast up to 2030.
The increasing popularity of precision medicine mainly enhances the pharmacogenomics market. It has also been seen that increasing research and development expenditure on pharmacogenomics technologies, is in turn, contributing to the fast development of novel products. The high prevalence rate of adverse drug reactions also leads to the increasing adoption of pharmacogenomics in the global market.…
Pharmacogenetic Testing Market, Competitive Strategies, Advertising Trends, & Ma …
Pharmacogenetic Testing Market will project a CAGR of 8.70% during the forecast period of 2023 to 2030.
The increasing popularity of precision medicine mainly enhances the pharmacogenomics market. It has also been seen that increasing research and development expenditure on pharmacogenomics technologies, is in turn, contributing to the fast development of novel products. The high prevalence rate of adverse drug reactions also leads to the increasing adoption of pharmacogenomics in the…
